Geron (GERN) News Today $2.58 -0.06 (-2.09%) Closing price 03:59 PM EasternExtended Trading$2.61 +0.03 (+1.36%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Geron to Participate at Upcoming Investor Conferences in March 2025February 21 at 8:58 PM | businesswire.comEquities Analysts Issue Forecasts for Geron FY2025 EarningsGeron Co. (NASDAQ:GERN - Free Report) - Equities researchers at B. Riley cut their FY2025 EPS estimates for shares of Geron in a research note issued to investors on Tuesday, February 18th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will earn ($0.08) per share forFebruary 21 at 6:47 AM | marketbeat.comB. Riley Comments on Geron's FY2027 Earnings (NASDAQ:GERN)February 21 at 3:31 AM | americanbankingnews.comGeron Corp (GERN) Announces Equity Awards to New EmployeesFebruary 20 at 8:30 PM | gurufocus.comWhat is B. Riley's Estimate for Geron FY2027 Earnings?Geron Co. (NASDAQ:GERN - Free Report) - Research analysts at B. Riley cut their FY2027 earnings estimates for shares of Geron in a note issued to investors on Tuesday, February 18th. B. Riley analyst K. Patel now forecasts that the biopharmaceutical company will post earnings of $0.28 per share fFebruary 20 at 7:42 AM | marketbeat.comB. Riley Has Lowered Expectations for Geron (NASDAQ:GERN) Stock PriceFebruary 20 at 2:45 AM | americanbankingnews.comGeron (NASDAQ:GERN) Given New $3.50 Price Target at B. RileyB. Riley decreased their price target on shares of Geron from $5.50 to $3.50 and set a "buy" rating for the company in a research note on Tuesday.February 19 at 4:09 PM | marketbeat.comB.Riley senkt Kursziel für Geron-Aktie auf 3,50 US-Dollar, behält Kaufempfehlung beiFebruary 19 at 11:48 AM | de.investing.comGeron (GERN) Projected to Post Earnings on WednesdayGeron (NASDAQ:GERN) will be releasing earnings before the market opens on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661683)February 19 at 3:22 AM | marketbeat.comAnalysts Set Geron Co. (NASDAQ:GERN) PT at $7.25Shares of Geron Co. (NASDAQ:GERN - Get Free Report) have received an average recommendation of "Buy" from the eleven ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and tFebruary 18 at 1:11 AM | marketbeat.comGeron Co. (NASDAQ:GERN) Given Average Recommendation of "Buy" by AnalystsGeron Co. (NASDAQ:GERN - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, eight have assigned a buy rating and two have assigned aFebruary 15, 2025 | marketbeat.comGeron (NASDAQ:GERN) Shares Down 4.6% - Should You Sell?Geron (NASDAQ:GERN) Trading Down 4.6% - Time to Sell?February 12, 2025 | marketbeat.comIs Geron Corp. (GERN) the Best Nasdaq Stock Under $5 to Buy?February 12, 2025 | insidermonkey.comGeron (NASDAQ:GERN) Trading Down 4.6% - Here's WhyGeron (NASDAQ:GERN) Stock Price Down 4.6% - What's Next?February 10, 2025 | marketbeat.comabrdn plc Purchases 360,027 Shares of Geron Co. (NASDAQ:GERN)abrdn plc boosted its position in Geron Co. (NASDAQ:GERN - Free Report) by 24.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,847,285 shares of the biopharmaceutical company's stock after acquiring an additional 360,027 shares during the period.February 9, 2025 | marketbeat.comIs Geron A Buyout Target? The RPRX Deal Says NoFebruary 4, 2025 | seekingalpha.comIs Geron A Buyout Target? The RPRX Deal Says NoFebruary 4, 2025 | seekingalpha.comGeron Corporation: Lackluster Share Price Performance Despite Reasonable Drug LaunchFebruary 3, 2025 | seekingalpha.comGeron Inc.: Strong Q4 Performance and Promising Growth Outlook Support Buy RatingJanuary 30, 2025 | markets.businessinsider.comStrategic IP Advancements and Revenue Projections Bolster Geron’s Buy RecommendationJanuary 30, 2025 | markets.businessinsider.comNvest Financial LLC Buys New Shares in Geron Co. (NASDAQ:GERN)Nvest Financial LLC purchased a new stake in shares of Geron Co. (NASDAQ:GERN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 195,741 shares of the biopharmaceutical company's stock, vJanuary 29, 2025 | marketbeat.comGeron (NASDAQ:GERN) shareholder returns have been stellar, earning 169% in 3 yearsJanuary 27, 2025 | finance.yahoo.comJPMorgan Chase & Co. Has $2.36 Million Stock Position in Geron Co. (NASDAQ:GERN)JPMorgan Chase & Co. lessened its holdings in shares of Geron Co. (NASDAQ:GERN - Free Report) by 40.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 519,674 shares of the biopharmaceutical company'January 22, 2025 | marketbeat.comGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 21, 2025 | businesswire.comGeron Co. (NASDAQ:GERN) Receives Consensus Recommendation of "Buy" from AnalystsGeron Co. (NASDAQ:GERN - Get Free Report) has been given an average rating of "Buy" by the eleven research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating oJanuary 21, 2025 | marketbeat.comGeron Corporation (GERN) Stock: An Under $5 Gem with Biggest Upside PotentialJanuary 20, 2025 | insidermonkey.comGeron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO SalesJanuary 16, 2025 | seekingalpha.comGeron (GERN) Receives a Buy from BarclaysJanuary 15, 2025 | markets.businessinsider.comGeron (NASDAQ:GERN) Stock Price Down 8.5% - Time to Sell?Geron (NASDAQ:GERN) Stock Price Down 8.5% - Here's What HappenedJanuary 15, 2025 | marketbeat.comStrong Growth and Strategic Financial Management Bolster Buy Rating for Geron’s Promising Rytelo DrugJanuary 15, 2025 | markets.businessinsider.comGeron’s Promising Market Growth: Strong Sales Performance and Optimistic Financial GuidanceJanuary 14, 2025 | markets.businessinsider.comGeron Corporation: Strong Market Performance and Strategic Advancements Justify Buy Rating and Increased Price TargetJanuary 13, 2025 | markets.businessinsider.comGeron (NASDAQ:GERN) Trading Down 8.5% - Time to Sell?Geron (NASDAQ:GERN) Shares Down 8.5% - Should You Sell?January 13, 2025 | marketbeat.comNeedham & Company LLC Issues Positive Forecast for Geron (NASDAQ:GERN) Stock PriceNeedham & Company LLC upped their price objective on shares of Geron from $6.00 to $7.00 and gave the company a "buy" rating in a report on Monday.January 13, 2025 | marketbeat.comFY2024 Earnings Forecast for Geron Issued By Leerink PartnrsGeron Co. (NASDAQ:GERN - Free Report) - Analysts at Leerink Partnrs lowered their FY2024 EPS estimates for Geron in a note issued to investors on Monday, January 6th. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will post earnings per share of ($0.29) forJanuary 8, 2025 | marketbeat.comGeron Inc.: Strategic Updates and Revised Launch Estimates Reinforce Buy RatingJanuary 8, 2025 | markets.businessinsider.comLeerink Partnrs Brokers Lower Earnings Estimates for GeronGeron Co. (NASDAQ:GERN - Free Report) - Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Geron in a note issued to investors on Monday, January 6th. Leerink Partnrs analyst F. Khurshid now expects that the biopharmaceutical company will post earnings per sharJanuary 7, 2025 | marketbeat.comIs Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?January 1, 2025 | insidermonkey.comGeron (NASDAQ:GERN) Trading 4.4% Higher - Here's What HappenedGeron (NASDAQ:GERN) Shares Up 4.4% - Time to Buy?December 31, 2024 | marketbeat.comGeron (GERN) Stock Surges on Game-Changing New TreatmentDecember 30, 2024 | tipranks.comGeron Corp. (GERN) Ends Trading Week Defying Market BloodbathDecember 28, 2024 | insidermonkey.comGeron Co. (NASDAQ:GERN) Receives Consensus Rating of "Buy" from AnalystsGeron Co. (NASDAQ:GERN - Get Free Report) has been assigned a consensus rating of "Buy" from the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and twoDecember 27, 2024 | marketbeat.comIs Geron Corp. (GERN) the Biggest Loser of This Week?December 26, 2024 | insidermonkey.comGeode Capital Management LLC Increases Holdings in Geron Co. (NASDAQ:GERN)Geode Capital Management LLC grew its stake in Geron Co. (NASDAQ:GERN - Free Report) by 1.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,067,999 shares of the biopharmaceutical company's stock afteDecember 22, 2024 | marketbeat.comGeron (NASDAQ:GERN) Stock Price Down 2.5% - Here's WhyGeron (NASDAQ:GERN) Trading Down 2.5% - What's Next?December 20, 2024 | marketbeat.comBarclays PLC Has $5.90 Million Stock Holdings in Geron Co. (NASDAQ:GERN)Barclays PLC increased its holdings in shares of Geron Co. (NASDAQ:GERN - Free Report) by 114.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,299,912 shares of the biopharmaceutical company's stock after buying an additionDecember 20, 2024 | marketbeat.comGeron Corp (GERN) Grants Stock Options to New EmployeesDecember 19, 2024 | gurufocus.comGeron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72%December 18, 2024 | finance.yahoo.comGeron (NASDAQ:GERN) Stock Price Up 3.7% - Here's WhyGeron (NASDAQ:GERN) Trading 3.7% Higher - Should You Buy?December 17, 2024 | marketbeat.comGeron Co. (NASDAQ:GERN) Short Interest Down 5.4% in NovemberGeron Co. (NASDAQ:GERN - Get Free Report) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 66,350,000 shares, a drop of 5.4% from the November 15th total of 70,130,000 shares. Based on an average daily trading volume, of 8,070,000 shares, the days-to-cover ratio is currently 8.2 days.December 17, 2024 | marketbeat.com Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address GERN Media Mentions By Week GERN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERN News Sentiment▼0.050.60▲Average Medical News Sentiment GERN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERN Articles This Week▼166▲GERN Articles Average Week Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALKS News Today IONS News Today FOLD News Today LGND News Today BCRX News Today DVAX News Today CLDX News Today MNKD News Today MYGN News Today NVAX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GERN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geron Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Geron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GERN Stock Alerts